Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Vyvanse in Bipolar Depression
NCT01131559Phase 3Terminated
- Sponsor
- Lindner Center of HOPE
- Start
- Jan 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Lisdexamfetamine Arm with Placebo Arm (2 arms). Primary endpoint: Montgomery-Åsberg Depression Rating Scale. Started Jan 2010; status: terminated.
02
Drugs
lisdexamfetamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01131559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131559.